SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene.

The identification of mutations in the SRY-related SOX9 gene in patients with campomelic dysplasia, a severe skeletal malformation syndrome, and the abundant expression of Sox9 in mouse chondroprogenitor cells and fully differentiated chondrocytes during embryonic development have suggested the hypo...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Mol Cell Biol
Principais autores:	Lefebvre, V, Huang, W, Harley, V R, Goodfellow, P N, de Crombrugghe, B
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis 1997
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC232082/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9121483/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/mcb.17.4.2336
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!